Cue Health (HLTH) Short Interest Ratio & Short Volume

Short interest is the volume of Cue Health shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 776,500 shares of HLTH short. 0.69% of Cue Health's shares are currently sold short. Learn More on Cue Health's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.69% of Cue Health's floating shares are currently sold short.

Cue Health saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 776,500 shares, an increase of 22.7% from the previous total of 632,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Cue Health currently has issued a total of 159,090,000 shares. Some of Cue Health's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cue Health currently has a public float of 112,030,000 shares.

0.69% of Cue Health's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Cue Health: Talis Biomedical Co. (0.55%), Accelerate Diagnostics, Inc. (1.94%), Telesis Bio, Inc. (0.18%), HTG Molecular Diagnostics, Inc. (0.07%), Singular Genomics Systems, Inc. (2.91%), ALX Oncology Holdings Inc. (16.09%), Cadrenal Therapeutics, Inc. (1.47%), Dare Bioscience, Inc. (0.53%), FibroGen, Inc (5.10%), Vor Biopharma Inc. (4.19%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Corporation ($3.10 billion), General Motors Company ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Corporation ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply Company ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

Short selling HLTH is an investing strategy that aims to generate trading profit from Cue Health as its price is falling. HLTH shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Cue Health occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HLTH, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HLTH, twice per month. The most recent reporting period available is May, 15 2024.